Skip to content

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

​​​​FTSE 100 struggles while DAX and Dow hold steady

​​The FTSE 100 remains under pressure in early trading, while both the Dax and Dow hold on near their previous highs. ​

Source: Bloomberg

​​​FTSE 100 under pressure

​The index has fallen back for several days, retreating from 7700 and the lower high of early February. ​ ​Having broken above trendline resistance from the 2023 highs during the course of late January, the price may now retest the broken trendline from above. This would also coincide with the 200-day simple moving average (ISMA). A recovery above 7600 might yet signal that a low has been formed. ​ ​Additional declines target the late January low at 7400, and below this down towards 7250 and the support zone that lasted throughout 2023.

Source: ProRealTime

​DAX holds near 17,000 ​

The Dax continues to consolidate around 17,000, but remains above trendline support from the October low. ​ ​Mid-January weakness found buyers at the 50-day SMA, and in the short-term a push to a fresh record high seems likely. ​ ​A near-term retracement requires a close back below the 50-day SMA to open the path to January’s low at 16,345, with some possible support before this at the previous record high of 16,532.

Source: ProRealTime

​Dow drifts through trendline support ​

In what might be seen as a portentous development, the Dow is testing support from the mid-January low. ​ ​In the short-term, further weakness could follow, potentially clearing the way to another test of the previous highs at 37,825. ​ ​Below this lies the 50-day SMA, and then down to 37,125, the lows of December.

Source: ProRealTime

Related articles

Live prices on most popular markets

  • Equities
  • Indices
  • Forex
  • Commodities
website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

" >


Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Monday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.


You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.


This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.